TITLE

Review: Magnesium is effective and safe for acute management of rapid atrial fibrillation

PUB. DATE
November 2007
SOURCE
ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p61
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information on a study, that investigated the use of magnesium for acute management of rapid atrial fibrillation (AF). It describes the procedure and randomized controlled trials (RCTs), that were carried out during the study. The study reveals that magnesium was more effective than placebo in achieving rate control in patients with rapid AF. It also states that magnesium is less effective than calcium-channel blockers for rate control but more effective for rhythm control.
ACCESSION #
28019861

 

Related Articles

  • COMMENTARY: Review: Magnesium is effective and safe for acute management of rapid atrial fibrillation. Dunn, Andrew // ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p61 

    The author reflects upon the findings of a study, that investigated the use of magnesium for acute management of rapid atrial fibrillation (AF). He criticizes the comparison between magnesium and placebo, that was included in the study. He also comments on the study's conclusion that magnesium...

  • Pulmonary Vein Isolation Compared to Rate Control in Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis. Vaidya, Kaivan; Arnott, Clare; Russell, Anne; Masson, Philip; Sy, Raymond W.; Patel, Sanjay // Heart, Lung & Circulation;Aug2015, Vol. 24 Issue 8, p744 

    Background Atrial fibrillation (AF) often coexists with congestive cardiac failure (CCF), with multiple treatment options available. Methods Systematic review and meta-analysis of randomised control trials (RCT) comparing pulmonary vein isolation (PVI), pharmacological rate control, and...

  • Placebo-Controlled Discontinuation of Long-Term Acid-Suppressant Therapy: A Randomised Trial in General Practice. Zwisler, Jon Eik; Jarbøl, Dorte Ejg; Lassen, Annmarie Touborg; Kragstrup, Jakob; Thorsgaard, Niels; Schaffalitzky de Muckadell, Ove B. // International Journal of Family Medicine;7/12/2015, Vol. 2015, p1 

    Objective. To investigate whether patients on long-term antisecretory medication need to continue treatment to control symptoms. Methods. A double-blinded randomised placebo-controlled trial in general practices in Denmark. Patients aged 18–90 who were treated with antisecretory drugs on...

  • Review: Antioxidant supplements for primary and secondary prevention do not decrease mortality.  // ACP Journal Club;Jul/Aug2007, Vol. 147 Issue 1, p4 

    The article cites a study, conducted by G. Bjelakovic and colleagues, which focuses on the effectiveness of antioxidant supplements (ASs) in decreasing mortality in healthy people or patients with chronic diseases. The study was published in an issue of the "Journal of American Medical...

  • Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials. Meissner, Karin; Distel, Hans; Mitzdorf, Ulla // BMC Medicine;2007, Vol. 5, p3 

    Background: Recent reviews on placebo effects in clinical trials suggest that objective changes following placebo treatments may not exist or, at least, have been considerably overestimated. However, the possibility that yet unidentified subsets of parameters are responsive to placebo ...

  • PACE - The first placebo controlled trial of paracetamol for acute low back pain: design of a randomised controlled trial. Williams, Christopher M.; Latimer, Jane; Maher, Christopher G.; McLachlan, Andrew J.; Cooper, Chris W.; Hancock, Mark J.; Day, Richard O.; McAuley, James H.; Lin, Chung-Wei Christine // BMC Musculoskeletal Disorders;2010, Vol. 11, p169 

    Background: Clinical practice guidelines recommend that the initial treatment of acute low back pain (LBP) should consist of advice to stay active and regular simple analgesics such as paracetamol 4 g daily. Despite this recommendation in all international LBP guidelines there are no placebo...

  • The use of intravenous magnesium in non-preeclamptic pregnant women: fetal/neonatal neuroprotection. Jacquemyn, Y.; Zecic, A.; Laere, D.; Roelens, K. // Archives of Gynecology & Obstetrics;May2015, Vol. 291 Issue 5, p969 

    Purpose: To review the effect of intravenous magnesium in obstetrics on fetal/neonatal neuroprotection. Methods: A systematic review of published studies. Results: Five randomized trials and 4 meta-analyses have shown a significant 32 % reduction of cerebral palsy when administering magnesium...

  • Antenatal interventions to reduce preterm birth: an overview of Cochrane systematic reviews. Piso, Brigitte; Zechmeister-Koss, Ingrid; Winkler, Roman // BMC Research Notes;2014, Vol. 7 Issue 1, p2 

    Background Several factors are associated with an increased risk of preterm birth (PTB); therefore, various interventions might have the potential to influence it. Due to the large number of interventions that address PTB, the objective of this overview is to summarise evidence from Cochrane...

  • Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis. Ho, Kwok M.; Sheridan, David J.; Paterson, Timothy // Heart;Nov2007, Vol. 93 Issue 11, p1433 

    Objectives: To assess the effects of intravenous magnesium on converting acute onset atrial fibrillation to sinus rhythm, reducing ventricular response and risk of bradycardia. Design and data sources: Randomised controlled trials evaluating intravenous magnesium to treat acute onset atrial...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics